GANX - Gain Therapeutics GAAP EPS of -$1.48 beats by $0.03 revenue of $0.14M beats by $0.02M March, 23 2023 04:41 PM Gain Therapeutics Inc. 2023-03-23 16:41:15 ET Gain Therapeutics press release ( NASDAQ: GANX ): FY GAAP EPS of -$1.48 beats by $0.03 . Revenue of $0.14M (-12.5% Y/Y) beats by $0.02M . For further details see: Gain Therapeutics GAAP EPS of -$1.48 beats by $0.03, revenue of $0.14M beats by $0.02M